Skip to content
10-Q

Quarterly Report

Ocera Therapeutics, Inc.

0001274644-17-000066

← back to feed
Filed
Aug 1, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Jul 31, 2017 26.51M sh
Operating Cash Flow Q2 2017 · Jun 30, 2017 −$10.88M
Operating Cash Flow Q2 2017 · Jun 30, 2016 −$10.85M
Cash And Equivalents Q2 2017 · Jun 30, 2017 $20.16M
Cash And Equivalents Q2 2017 · Dec 31, 2016 $24.61M
Cash And Equivalents Q2 2017 · Jun 30, 2016 $34.19M
Cash And Equivalents Q2 2017 · Dec 31, 2015 $35.92M
Stockholders Equity Q2 2017 · Jun 30, 2017 $9.27M
Stockholders Equity Q2 2017 · Dec 31, 2016 $15.74M
Current Liabilities Q2 2017 · Jun 30, 2017 $12.42M
Current Liabilities Q2 2017 · Dec 31, 2016 $13.76M
Total Liabilities Q2 2017 · Jun 30, 2017 $12.42M
Total Liabilities Q2 2017 · Dec 31, 2016 $13.9M
Current Assets Q2 2017 · Jun 30, 2017 $21.05M
Current Assets Q2 2017 · Dec 31, 2016 $28.94M
Total Assets Q2 2017 · Jun 30, 2017 $21.68M
Total Assets Q2 2017 · Dec 31, 2016 $29.64M
Sga Expense Q2 2017 · Jun 30, 2017 $2.5M
Sga Expense Q2 2017 · Jun 30, 2017 $5.02M
Sga Expense Q2 2017 · Jun 30, 2016 $2.97M
Sga Expense Q2 2017 · Jun 30, 2016 $5.52M
Rd Expense Q2 2017 · Jun 30, 2017 $3.41M
Rd Expense Q2 2017 · Jun 30, 2017 $7.31M
Rd Expense Q2 2017 · Jun 30, 2016 $3.91M
Rd Expense Q2 2017 · Jun 30, 2016 $8.66M
Net Income Q2 2017 · Jun 30, 2017 −$6.13M
Net Income Q2 2017 · Jun 30, 2017 −$12.82M
Net Income Q2 2017 · Jun 30, 2016 −$7.1M
Net Income Q2 2017 · Jun 30, 2016 −$14.62M